Literature DB >> 12433990

Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter.

C Perez-Sanchez1, V S Budhram-Mahadeo, D S Latchman.   

Abstract

Although the promoters of both the Bax and p21 genes are activated by p53, they differ in the effect on this activation of the POU family transcription factor Brn-3a. Thus, Brn-3a inhibits activation of the Bax promoter by p53 but enhances the ability of p53 to activate the p21 promoter. We demonstrate that repression of p53-mediated activation of the Bax promoter involves a complex upstream sequence in which two Brn-3a response elements flank the p53 response element. In contrast, a minimal p21 promoter is activated by Brn-3a and such activation cannot be abolished without abolishing basal promoter activity. Moreover, synergistic activation by Brn-3a and p53 continues to be observed when the p53-binding sites in the p21 promoter are substituted by the Bax p53 site or by the region of the Bax promoter essential for Brn-3a-mediated repression, indicating that the p21 core promoter plays a central role in this response. The significance of these effects is discussed in terms of the different responses of the Bax and p21 promoters and the overlapping but distinct roles of Brn-3a and p53 in neuronal growth arrest and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12433990      PMCID: PMC137158          DOI: 10.1093/nar/gkf610

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53.

Authors:  K L Sugars; V Budhram-Mahadeo; G Packham; D S Latchman
Journal:  Nucleic Acids Res       Date:  2001-11-15       Impact factor: 16.971

2.  ASPP proteins specifically stimulate the apoptotic function of p53.

Authors:  Y Samuels-Lev; D J O'Connor; D Bergamaschi; G Trigiante; J K Hsieh; S Zhong; I Campargue; L Naumovski; T Crook; X Lu
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

3.  p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor.

Authors:  V Budhram-Mahadeo; P J Morris; M D Smith; C A Midgley; L M Boxer; D S Latchman
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

4.  Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.

Authors:  X T Kong; H Gao; E J Stanbridge
Journal:  J Biol Chem       Date:  2001-06-06       Impact factor: 5.157

5.  Autoregulatory sequences are revealed by complex stability screening of the mouse brn-3.0 locus.

Authors:  M Trieu; J M Rhee; N Fedtsova; E E Turner
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

6.  Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein.

Authors:  G Koutsodontis; I Tentes; P Papakosta; A Moustakas; D Kardassis
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

7.  Defects in sensory axon growth precede neuronal death in Brn3a-deficient mice.

Authors:  S R Eng; K Gratwick; J M Rhee; N Fedtsova; L Gan; E E Turner
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

8.  The POU domain transcription factor Brn-3a protects cortical neurons from apoptosis.

Authors:  M D Smith; E A Ensor; R A Kinloch; D S Latchman
Journal:  Neuroreport       Date:  2001-10-29       Impact factor: 1.837

9.  Brn-3a activates the expression of Bcl-x(L) and promotes neuronal survival in vivo as well as in vitro.

Authors:  M D Smith; L A Melton; E A Ensor; G Packham; P Anderson; R A Kinloch; D S Latchman
Journal:  Mol Cell Neurosci       Date:  2001-03       Impact factor: 4.314

10.  The BRN-3A transcription factor protects sensory but not sympathetic neurons from programmed cell death/apoptosis.

Authors:  E Ensor; M D Smith; D S Latchman
Journal:  J Biol Chem       Date:  2000-10-25       Impact factor: 5.157

View more
  7 in total

1.  Apoptotic signaling proteins: possible participation in the regulation of vasopressin and catecholamines biosynthesis in the hypothalamus.

Authors:  Elena V Chernigovskaya; Andrey G Taranukhin; Margarita V Glazova; Liubov A Yamova; Lev M Fedorov
Journal:  Histochem Cell Biol       Date:  2005-08-25       Impact factor: 4.304

2.  Life or death: p53-induced apoptosis requires DNA binding cooperativity.

Authors:  Katharina Schlereth; Joël P Charles; Anne C Bretz; Thorsten Stiewe
Journal:  Cell Cycle       Date:  2010-10-11       Impact factor: 4.534

3.  A simple technique for the prediction of interacting proteins reveals a direct Brn-3a-androgen receptor interaction.

Authors:  Daniel C Berwick; James K J Diss; Vishwanie S Budhram-Mahadeo; David S Latchman
Journal:  J Biol Chem       Date:  2010-03-12       Impact factor: 5.157

4.  Neuronal transcription factor Brn-3a(l) is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer.

Authors:  Nuzhat Ahmed; Ardian Latifi; Clyde B Riley; Jock K Findlay; Michael A Quinn
Journal:  J Ovarian Res       Date:  2010-07-29       Impact factor: 4.234

5.  Essential but partially redundant roles for POU4F1/Brn-3a and POU4F2/Brn-3b transcription factors in the developing heart.

Authors:  Lauren J Maskell; Kashif Qamar; Aram A Babakr; Thomas A Hawkins; Richard J Heads; Vishwanie S Budhram-Mahadeo
Journal:  Cell Death Dis       Date:  2017-06-08       Impact factor: 8.469

6.  Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression.

Authors:  Vishwanie S Budhram-Mahadeo; Samantha Bowen; Sonia Lee; Christina Perez-Sanchez; Elizabeth Ensor; Peter J Morris; David S Latchman
Journal:  Nucleic Acids Res       Date:  2006-12-01       Impact factor: 16.971

7.  Pou4f1 and pou4f2 are dispensable for the long-term survival of adult retinal ganglion cells in mice.

Authors:  Liang Huang; Fang Hu; Xiaoling Xie; Jeffery Harder; Kimberly Fernandes; Xiang-yun Zeng; Richard Libby; Lin Gan
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.